Skip Navigation
Celldex Therapeutics logo Celldex logo
Main Nav
  • Our Company
    • About Us
    • Leadership
      • Management
      • Board of Directors
      • Scientific Advisory Board
    • Contact Us
  • Pipeline
    • Pipeline Overview
    • Therapeutic Areas
      • Inflammation
      • Oncology
    • Clinical Trials
      • Compassionate Use
  • Science
    • Antibody-Based Therapeutics
      • Bispecific Platform
    • Publications
  • Investors & Media
    • Investor & Media Home
    • Press Releases
    • Events & Presentations
    • Analyst Coverage
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Annual Reports & Proxies
    • Corporate Governance
      • Documents & Charters
      • Management
      • Board of Directors
      • Scientific Advisory Board
      • Committee Composition
    • Investor Resources
      • Contact Us
      • Email Alerts
  • Careers
  • Contact Us
  • Search Toggle
background image of cells and shapes
Investors
& Media

SEC Filing Details

« Back

Document Details

Form
10-K
Filing Date
Feb 28, 2022
Document Date
Dec 31, 2021
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Main Nav
  • Investor & Media Home
  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
    • Annual Reports & Proxies
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Committee Composition
  • Investor Resources
    • Contact Us
    • Email Alerts

Investor & Media Inquiries

Sarah Cavanaugh
Senior Vice President
Corporate Affairs and Administration
 
IR@celldex.com
Celldex Therapeutics logo
info@celldex.com
53 Frontage Road
Suite 220
Hampton NJ 08827
(908) 454-7120
300 George Street
Suite 530
New Haven, CT 06511
(203) 483-3500
151 Martine Street
Fall River, MA 02723


(508) 742-4300
160 Gould Street
Suite 202
Needham, MA 02494

(781) 433-0771

©2023 Celldex Therapeutics. All Rights Reserved.

Footer Links
  • Privacy Policy
  • Research Conflicts of Interest Policy
  • Terms of Use
  • Site Map